• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸西地那非对五只艾森曼格综合征犬的影响。

Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome.

作者信息

Nakamura K, Yamasaki M, Ohta H, Sasaki N, Murakami M, Bandula Kumara W R, Takiguchi M

机构信息

Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Hokkaido 060-0818, Japan.

出版信息

J Small Anim Pract. 2011 Nov;52(11):595-8. doi: 10.1111/j.1748-5827.2011.01127.x. Epub 2011 Oct 10.

DOI:10.1111/j.1748-5827.2011.01127.x
PMID:21985577
Abstract

OBJECTIVES

To determine the effect of sildenafil for dogs with Eisenmeger's syndrome and secondary erythrocytosis.

METHODS

This is a prospective, single arm, open-label study. Five clinical dogs with Eisenmeger's syndrome and secondary erythrocytosis were included. New York Heart Association functional class, packed cell volume, pulmonary artery acceleration time to ejection time ratio and serum erythropoietin concentration were evaluated before and after sildenafil therapy (0·5 mg/kg, twice a day).

RESULTS

New York Heart Association functional class was significantly improved after one (median 2; range 1 to 2, P=0·031) and three months (median 2; range 1 to 2, P=0·031) of sildenafil therapy, compared with the baseline (median 3, range 2 to 3). Packed cell volume was significantly decreased after three months (median 59%; range 56 to 63, P=0·031) of therapy, compared with the baseline (median 71%; range 58 to 74). Acceleration time to ejection time ratio had increased and serum erythropoietin concentration had decreased particularly after 1 month of therapy, but there was no statistical significance.

CLINICAL SIGNIFICANCE

Sildenafil improved the clinical signs and secondary erythrocytosis in dogs with Eisenmeger's syndrome. Sildenafil therapy could be a useful treatment for dogs with Eisenmeger's syndrome.

摘要

目的

确定西地那非对患有艾森曼格综合征和继发性红细胞增多症的犬的疗效。

方法

这是一项前瞻性、单臂、开放标签研究。纳入了5只患有艾森曼格综合征和继发性红细胞增多症的临床犬。在西地那非治疗前后(0.5mg/kg,每日两次)评估纽约心脏协会心功能分级、红细胞压积、肺动脉加速时间与射血时间比值以及血清促红细胞生成素浓度。

结果

与基线(中位数3,范围2至3)相比,西地那非治疗1个月(中位数2;范围1至2,P = 0.031)和3个月(中位数2;范围1至2,P = 0.031)后,纽约心脏协会心功能分级显著改善。治疗3个月后,与基线(中位数71%;范围58至74)相比,红细胞压积显著降低(中位数59%;范围56至63,P = 0.031)。特别是在治疗1个月后,加速时间与射血时间比值增加,血清促红细胞生成素浓度降低,但无统计学意义。

临床意义

西地那非改善了患有艾森曼格综合征犬的临床症状和继发性红细胞增多症。西地那非治疗可能是患有艾森曼格综合征犬的一种有效治疗方法。

相似文献

1
Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome.枸橼酸西地那非对五只艾森曼格综合征犬的影响。
J Small Anim Pract. 2011 Nov;52(11):595-8. doi: 10.1111/j.1748-5827.2011.01127.x. Epub 2011 Oct 10.
2
Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.西地那非治疗继发于房间隔缺损与室间隔缺损的艾森曼格综合征的疗效比较:一项心导管插入术随访研究
Cardiol Young. 2011 Dec;21(6):631-8. doi: 10.1017/S1047951111000497. Epub 2011 Jun 8.
3
Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.口服西地那非治疗艾森曼格综合征:一项前瞻性、开放标签、多中心研究。
Heart. 2011 Nov;97(22):1876-81. doi: 10.1136/heartjnl-2011-300344. Epub 2011 Sep 21.
4
Impact of sildenafil on survival of patients with Eisenmenger syndrome.西地那非对艾森曼格综合征患者生存的影响。
J Clin Pharmacol. 2013 Jun;53(6):611-8. doi: 10.1002/jcph.78. Epub 2013 Mar 30.
5
A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.一项随机、安慰剂对照、双盲、交叉研究,以评估口服西地那非治疗重度肺动脉高压的疗效。
Am Heart J. 2006 Apr;151(4):851.e1-5. doi: 10.1016/j.ahj.2005.09.006.
6
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.口服西地那非长期治疗对肺动脉高压患者是安全的,并能改善其功能容量和血流动力学。
Circulation. 2003 Oct 28;108(17):2066-9. doi: 10.1161/01.CIR.0000099502.17776.C2. Epub 2003 Oct 20.
7
Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.慢性西地那非对艾森曼格综合征患者与特发性肺动脉高压患者的影响。
Int J Cardiol. 2007 Sep 3;120(3):301-5. doi: 10.1016/j.ijcard.2006.10.018. Epub 2006 Dec 14.
8
Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.肺动脉高压患者从皮下注射曲前列尼尔转换为口服西地那非的安全性和有效性。
J Heart Lung Transplant. 2007 Nov;26(11):1079-83. doi: 10.1016/j.healun.2007.07.040. Epub 2007 Oct 24.
9
Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.口服西地那非治疗艾森曼格综合征可改善患者的生活质量和功能能力。
Int J Cardiol. 2011 Jun 16;149(3):372-6. doi: 10.1016/j.ijcard.2010.02.020. Epub 2010 Mar 20.
10
Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.13只接受西地那非治疗的肺动脉高压(PH)犬的临床特征及预后
J Vet Intern Med. 2007 Nov-Dec;21(6):1165.

引用本文的文献

1
Peritoneo pericardial hernioplasty in a 2-month-old Shih Tzu.一只2个月大的西施犬的腹膜心包疝修补术。
Open Vet J. 2025 May;15(5):2259-2264. doi: 10.5455/OVJ.2025.v15.i5.43. Epub 2025 May 31.
2
Successful treatment of patent ductus arteriosus and severe pulmonary hypertension using sildenafil and beraprost sodium in two dogs.西地那非和贝拉普罗斯特钠成功治疗两只犬的动脉导管未闭和重度肺动脉高压
J Vet Med Sci. 2025 Jul 7;87(7):798-803. doi: 10.1292/jvms.25-0097. Epub 2025 May 26.
3
Case report: Eisenmenger syndrome in a dog with ventricular septal defect: long term management and complications.
病例报告:一只患有室间隔缺损的犬的艾森曼格综合征:长期管理及并发症
Front Vet Sci. 2024 Nov 1;11:1393919. doi: 10.3389/fvets.2024.1393919. eCollection 2024.
4
Clinical features and outcome of dogs and cats with bidirectional and continuous right-to-left shunting patent ductus arteriosus.犬猫双向持续动脉导管左向右分流的临床特征和转归。
J Vet Intern Med. 2021 Mar;35(2):780-788. doi: 10.1111/jvim.16072. Epub 2021 Feb 26.
5
Short-term effects of sildenafil in the treatment of dogs with pulmonary hypertension secondary to degenerative mitral valve disease.西地那非治疗退行性二尖瓣疾病继发肺动脉高压犬的短期疗效
Vet World. 2020 Oct;13(10):2260-2268. doi: 10.14202/vetworld.2020.2260-2268. Epub 2020 Oct 29.
6
Pharmacokinetics of single dose sildenafil orally administered in canine models of chronic embolic pulmonary hypertension.单剂量西地那非口服给药在慢性栓塞性肺动脉高压犬模型中的药代动力学
J Vet Med Sci. 2020 Apr 9;82(4):446-451. doi: 10.1292/jvms.19-0595. Epub 2020 Feb 26.
7
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.ACVIM 共识声明指南:犬肺动脉高压的诊断、分类、治疗和监测。
J Vet Intern Med. 2020 Mar;34(2):549-573. doi: 10.1111/jvim.15725. Epub 2020 Feb 17.
8
Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.他达拉非与西地那非治疗中度至重度犬肺动脉高压的临床疗效:一项初步研究。
J Vet Cardiol. 2019 Aug;24:7-19. doi: 10.1016/j.jvc.2019.05.001. Epub 2019 May 11.
9
Use of sildenafil citrate in a cat with Eisenmenger's syndrome and an atrial septal defect.枸橼酸西地那非在一只患有艾森曼格综合征和房间隔缺损的猫中的应用。
JFMS Open Rep. 2015 Apr 28;1(1):2055116915579680. doi: 10.1177/2055116915579680. eCollection 2015 Jan-Jun.